ShadowBuys
Sign inJoin for free

Pfizer (PFE)

Healthcare · Drug Manufacturers - General

39 members of Congress have disclosed 193 trades in Pfizer (PFE) since 2015: 75 buys and 118 sales. The most recent was disclosed on Oct 7, 2026. 3 trades were made by members of a committee that oversees Pfizer's industry.

Trades disclosed
193
Members trading
39
Buys / sells
75 / 118
Reported value
$1.2M–$5.3M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow PFE

What else is happening at PFE

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. PFECompany announcement·SEC EDGAR

    PFE: Leadership change

    Filed 8-K for an event or period dated 2026-10-30. Leadership change.

    Public: Nov 3, 2026, 4:19 PM ESTEvent / period: Oct 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. PFEFinancial report·SEC EDGAR

    PFE: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-27. Read the company report for its disclosures.

    Public: Nov 3, 2026, 8:19 AM ESTEvent / period: Sep 27, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. PFECompany announcement·SEC EDGAR

    PFE: Financial results

    Filed 8-K for an event or period dated 2026-11-03. Financial results.

    Public: Nov 3, 2026, 8:07 AM ESTEvent / period: Nov 3, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. PFERegulatory notice·Federal Register

    Jeffrey Thies: Final Debarment Order

    The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jeffrey Thies for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Thies was convicted of two felony counts under Federal law for trafficking in counterfeit goods and aiding and abetting. The factual basis supporting Mr. Thies's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Thies was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of July 13, 2026 (more than 30 days after receipt of the notice), Mr. Thies had not responded. Mr. Thies's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

    Public: Sep 25, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. PFERegulatory notice·Federal Register

    Advisory Committee; Oncologic Drugs Advisory Committee; Renewal

    The Food and Drug Administration (FDA) is announcing the renewal of the Oncologic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Oncologic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the September 1, 2028, expiration date.

    Public: Aug 21, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees Pfizer's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded PFE

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.